Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Clostridium difficile in western Romania: unfavourable outcome predictors in a hospital for infectious diseases

Authors: Ruxandra Laza, Ruxandra Jurac, Alexandru Crişan, Voichiţa Lăzureanu, Monica Licker, Emilian Damian Popovici, Luminiţa Mirela Bădiţoiu

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

The recent emergence of Clostridium difficile infections has included this condition among top nosocomial infections, due to its incidence, complications and important fatality, as well as to significant economic costs.

Methods

A prospective surveillance study of Clostridium difficile enterocolitis cases was performed in “Victor Babeş” Infectious Diseases Hospital in Timişoara (Romania) between 01.01.2013 - 30.06.2014, to estimate the incidence and to investigate the risk factors for unfavourable outcome and relapse. Dichotomous variables were compared by the chi-square test or Fisher exact test and the Mann–Whitney U test was used for continuous variables. Risk factors for unfavourable outcome/recurrence were investigated by logistic regression.

Results

210 patients who experienced 219 episodes of infection with Clostridium difficile were identified, which gives an incidence per hospital of 20.57/15.70 to 1,000 discharged patients in 2013/2014 or 17.73/14.04 to 10,000 patient-days. In 162 patients (77.14%) the evolution was favourable while in 48 (22.86%) the outcome was unfavourable. In 42 patients (20.00%) recurrence of symptoms was identified. The multivariate analysis by logistic regression identified the ATLAS score (OR = 4.97, 95% CI = 2.12 to 11.66, p <0.001), age (OR = 1.12, 95% CI = 1.00 to 1.25, p = 0.046), and the number of antibiotics after episode onset (OR = 2.692, 95% CI = 1.01 to 7.17, p = 0.047) as predictors of an unfavourable evolution, while the number of hospitalization days (OR = 1.10, 95% CI = 1.03 to 1.16, p = 0.0015) was associated with recurrence of symptoms.

Conclusions

The high incidence identified in our study is explained by the endemic character of these infections in some hospitals in Timişoara, released in late 2012, and the fact that “Victor Babeş” Hospital is the only one in our area that provides treatment in all suspected or confirmed cases of this condition requiring hospitalization. The study identified the ATLAS score, age, and the number of antibiotics after episode onset as predictors of unfavourable evolution, while the number of days of hospitalization was associated with the recurrence of symptoms.
Literature
3.
go back to reference Rodríguez-Pardo D, Almirante B, Bartolomé RM, Pomar V, Mirelis B, Navarro F, et al. Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavourable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain. J Clin Microbiol. 2013;51(5):1465–73.CrossRefPubMedPubMedCentral Rodríguez-Pardo D, Almirante B, Bartolomé RM, Pomar V, Mirelis B, Navarro F, et al. Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavourable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain. J Clin Microbiol. 2013;51(5):1465–73.CrossRefPubMedPubMedCentral
4.
go back to reference Alcalá L, Marin M, Martin A, Sánchez-Somolinos M, Catalán P, Peláez MT, et al. Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey. J Hosp Infect. 2011;79(1):13–7.CrossRefPubMed Alcalá L, Marin M, Martin A, Sánchez-Somolinos M, Catalán P, Peláez MT, et al. Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey. J Hosp Infect. 2011;79(1):13–7.CrossRefPubMed
5.
go back to reference Centrul National de Supraveghere si Control al Bolilor Transmisibile. Metodologia de supraveghere a infecţiei cu Clostridium difficile [https://www.insp.gov.ro/cnscbt/index.php?option = com_docman&task = doc_download&gid = 725&Itemid = 35]. Accessed 02.07.2014. Centrul National de Supraveghere si Control al Bolilor Transmisibile. Metodologia de supraveghere a infecţiei cu Clostridium difficile [https://​www.​insp.​gov.​ro/​cnscbt/​index.​php?​option = com_docman&task = doc_download&gid = 725&Itemid = 35]. Accessed 02.07.2014.
7.
go back to reference Popescu GA, Gavriliu LC, Petrache D, Pitic D. Particularităţile cazurilor de infecţii cauzate de Clostridium difficile internate in anul 2011 într-un spital de boli infecţioase din Bucureşti. Infectio. 2011;26(2):36–8. Popescu GA, Gavriliu LC, Petrache D, Pitic D. Particularităţile cazurilor de infecţii cauzate de Clostridium difficile internate in anul 2011 într-un spital de boli infecţioase din Bucureşti. Infectio. 2011;26(2):36–8.
10.
go back to reference Balihar K, Kozak F, Kozeluhova J, Hejda V, Fremundova L, Krcma M, et al. Clostridium difficile infection in hospitalized patients at a Czech tertiary center: analysis of epidemiology, clinical features, and risk factors of fulminant course. Eur J Gastroen Hepat. 2014;26(8):880–7.CrossRef Balihar K, Kozak F, Kozeluhova J, Hejda V, Fremundova L, Krcma M, et al. Clostridium difficile infection in hospitalized patients at a Czech tertiary center: analysis of epidemiology, clinical features, and risk factors of fulminant course. Eur J Gastroen Hepat. 2014;26(8):880–7.CrossRef
13.
go back to reference Morrison RH, Hall NS, Said M, Rice T, Groff H, Brodine SK, et al. Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection. Clin Infect Dis. 2011;53(12):1173–8.CrossRefPubMed Morrison RH, Hall NS, Said M, Rice T, Groff H, Brodine SK, et al. Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection. Clin Infect Dis. 2011;53(12):1173–8.CrossRefPubMed
14.
go back to reference Ramírez-Rosales A, Cantú-Llanos E. Intrahospital mortality in patients with Clostridium difficile-associated diarrhea infection. Rev Gastroenterol Mex. 2012;77(2):60–5.PubMed Ramírez-Rosales A, Cantú-Llanos E. Intrahospital mortality in patients with Clostridium difficile-associated diarrhea infection. Rev Gastroenterol Mex. 2012;77(2):60–5.PubMed
15.
go back to reference Klobuka AJ, Markelov A. Current status of surgical treatment for fulminant Clostridium difficile colitis. World J Gastrointest Surg. 2013;5(6):167–72.CrossRefPubMedPubMedCentral Klobuka AJ, Markelov A. Current status of surgical treatment for fulminant Clostridium difficile colitis. World J Gastrointest Surg. 2013;5(6):167–72.CrossRefPubMedPubMedCentral
16.
go back to reference Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect. 2011;79(4):359–63.CrossRefPubMed Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect. 2011;79(4):359–63.CrossRefPubMed
17.
go back to reference Bhangu S, Bhangu A, Nightingale P, Michael A. Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea. Colorectal Dis. 2010;12:241–6.CrossRefPubMed Bhangu S, Bhangu A, Nightingale P, Michael A. Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea. Colorectal Dis. 2010;12:241–6.CrossRefPubMed
18.
go back to reference Zilberberg MD, Shorr AF, Micek ST, Doherty JA, Kollef MH. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med. 2009;37:2583–9.CrossRefPubMed Zilberberg MD, Shorr AF, Micek ST, Doherty JA, Kollef MH. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med. 2009;37:2583–9.CrossRefPubMed
19.
go back to reference Taori SK, Wroe A, Poxton IR. Clostridium difficile infections in South East Scotland: mortality and recurrence in a region without PCR ribotype 027. J Med Microbiol. 2013;62:1468–77.CrossRefPubMed Taori SK, Wroe A, Poxton IR. Clostridium difficile infections in South East Scotland: mortality and recurrence in a region without PCR ribotype 027. J Med Microbiol. 2013;62:1468–77.CrossRefPubMed
20.
go back to reference Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing Prevalence and Severity of Clostridium difficile Colitis in Hospitalized Patients in the United States. Arch Surg. 2007;142(7):624–31.CrossRefPubMed Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing Prevalence and Severity of Clostridium difficile Colitis in Hospitalized Patients in the United States. Arch Surg. 2007;142(7):624–31.CrossRefPubMed
21.
go back to reference Markelov A, Livert D, Kohli H. Predictors of Fatal Outcome after Colectomy for Fulminant Clostridium difficile Colitis: A 10-Year Experience. Am Surgeon. 2011;7(8):977. Markelov A, Livert D, Kohli H. Predictors of Fatal Outcome after Colectomy for Fulminant Clostridium difficile Colitis: A 10-Year Experience. Am Surgeon. 2011;7(8):977.
22.
go back to reference Im GY, Modayil RJ, Feuerman M, Lin CT, Balani AR, Katz DS, et al. A prediction model of disease severity in Clostridium difficile-associated disease [abstract]. Gastroenterology. 2011;140(S1):S361. Im GY, Modayil RJ, Feuerman M, Lin CT, Balani AR, Katz DS, et al. A prediction model of disease severity in Clostridium difficile-associated disease [abstract]. Gastroenterology. 2011;140(S1):S361.
23.
go back to reference Owens Jr RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-Associated Risk Factors for Clostridium difficile Infection. Clin Infect Dis. 2008;46(S1):S19–31.CrossRefPubMed Owens Jr RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-Associated Risk Factors for Clostridium difficile Infection. Clin Infect Dis. 2008;46(S1):S19–31.CrossRefPubMed
24.
go back to reference Hu MY, Katchar K, Kyne L, Maroo S, Tummala S, Dreisbach V, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology. 2009;136:1206–14.CrossRefPubMed Hu MY, Katchar K, Kyne L, Maroo S, Tummala S, Dreisbach V, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology. 2009;136:1206–14.CrossRefPubMed
Metadata
Title
Clostridium difficile in western Romania: unfavourable outcome predictors in a hospital for infectious diseases
Authors
Ruxandra Laza
Ruxandra Jurac
Alexandru Crişan
Voichiţa Lăzureanu
Monica Licker
Emilian Damian Popovici
Luminiţa Mirela Bădiţoiu
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0895-y

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.